Secondaries announced 9.21.2015
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Concordia Healthcare Symbol: CXRX Price: Last trade $72.23 Trade Date: 9/25 Shares: 8 million Underwriter(s) Goldman Sachs, RBC Capital Markets, Credit[…]